Subclinical atherosclerosis in young Thai adults with juvenile-onset systemic lupus erythematosus

被引:0
|
作者
Pattrakornkul, Nalinee [1 ]
Pruangprasert, Patamakom [1 ]
Chanthong, Prakul [1 ]
Chawanasuntorapoj, Ratana [2 ]
Pattaragarn, Anirut [1 ]
机构
[1] Mahidol Univ, Siriraj Hosp, Dept Pediat, Fac Med, Bangkok 10700, Thailand
[2] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Med, Bangkok 10700, Thailand
关键词
Atherosclerosis; carotid intima-media thickness; juvenile-onset systemic lupus erythematosus; subclinical atherosclerosis; systemic lupus erythematosus; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; CYCLOSPORINE-A; BLOOD-PRESSURE; PROGRESSION; ALBUMINURIA; NEPHRITIS; UPDATE;
D O I
10.5372/1905-7415.1002.475
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in adult patients with systemic lupus erythematosus (SLE). Increased risk of CVD and atherosclerosis has been demonstrated in children with SLE. However, evidence of atherosclerosis in adults with juvenile-onset SLE is limited and their additional CVD risk factors unclear. Objectives: To investigate the presence of subclinical atherosclerosis in young Thai adults with juvenile-onset SLE, and evaluate atherosclerotic risk factors. Methods: We recruited a cohort of patients aged 18-40 years who had been diagnosed SLE before the age of 18 years for this observational study. Patients with chronic kidney disease stage IV or V, alcoholism, chronic liver disease, or life threatening illness were excluded. Common carotid intima-media thickness (CCIMT) was measured. Clinical and laboratory parameters, treatment, and SLE-related factors, which could be risk factors for atherosclerosis and classic risk factors were obtained. Results: We enrolled 29 patients (24 female). Their mean age was 25.1 years and mean disease duration 11.3 years. The age of participants, persistent proteinuria and use of cyclosporin correlated with increased CCIMT by multivariable analysis (P = 0.02, 0.02, and 0.03, respectively). These patients had significantly abnormal CCIMT when compared with a healthy population (mean 690 (SD 150) mu m versus mean 447 (SD 76) mu m, respectively; P < 0.001). Conclusions: Subclinical atherosclerosis, identified by abnormal CCIMT, appears in young adults with juvenile-onset SLE. The CCIMT abnormality progresses with increasing age, and persistent proteinuria and use of cyclosporin appears to increase the risk for atherosclerosis.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 50 条
  • [41] Subclinical atherosclerosis in systemic lupus erythematosus
    Ahmad, Y
    Bruce, IN
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (05) : 841 - 843
  • [42] Co-existence of juvenile-onset systemic lupus erythematosus and juvenile myasthenia gravis
    Sampath, S.
    McCann, L. J.
    McDonagh, J.
    Cleary, G.
    Spinty, S.
    Pain, C. E.
    Baildam, E. M.
    Beresford, M. W.
    LUPUS, 2015, 24 (13) : 1462 - 1463
  • [43] Vitamin D levels in children, adolescents, and young adults with juvenile-onset systemic lupus erythematosus: a cross-sectional study
    Stagi, S.
    Cavalli, L.
    Bertini, F.
    de Martino, M.
    Cerinic, M. Matucci
    Brandi, M. L.
    Falcini, F.
    LUPUS, 2014, 23 (10) : 1059 - 1065
  • [44] Genetic and epigenetic factors shape phenotypes and outcomes in systemic lupus erythematosus focus on juvenile-onset systemic lupus erythematosus
    Charras, Amandine
    Hiraki, Linda T.
    Lewandowski, Laura
    Hedrich, Christian M.
    CURRENT OPINION IN RHEUMATOLOGY, 2025, 37 (02) : 149 - 163
  • [45] Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus
    Falaschi, F
    Ravelli, A
    Martignoni, A
    Migliavacca, D
    Sartori, M
    Pistorio, A
    Perani, G
    Martini, A
    ARTHRITIS AND RHEUMATISM, 2000, 43 (06): : 1405 - 1409
  • [46] DIAGNOSIS AND INITIAL MANAGEMENT OF JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS IN THE UK AND IRELAND
    Lythgoe, Hanna
    Pain, Clare
    Smith, Eve
    Beresford, Michael
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1329 - 1329
  • [47] Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients
    Eissa, Eman
    Morcos, Botros
    Dorgham, Dalia
    Kholoussi, Naglaa
    ARCHIVES OF RHEUMATOLOGY, 2022, 37 (03) : 417 - 423
  • [48] Increased incidence of juvenile-onset systemic lupus erythematosus among children with asthma
    Wei, Chang-Ching
    Lin, Cheng-Li
    Shen, Te-Chun
    Tsai, Jeng-Dau
    Chung, Chi-Jung
    Li, Tsai-Chung
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2014, 25 (04) : 374 - 379
  • [49] Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus
    Kamal El Garf
    Huda Marzouk
    Yomna Farag
    Laila Rasheed
    Ayman El Garf
    Rheumatology International, 2015, 35 : 1535 - 1540
  • [50] Major infections in a cohort of 120 patients with juvenile-onset systemic lupus erythematosus
    Costa-Reis, Patricia
    Nativ, Simona
    Isgro, Josephine
    Rodrigues, Teresa
    Yildirim-Toruner, Cagri
    Starr, Amy
    Saiman, Lisa
    Lmundo, Lisa
    Eichenfield, Andrew
    CLINICAL IMMUNOLOGY, 2013, 149 (03) : 442 - 449